You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
20009- Partha
SBC: CFD RESEARCH CORPORATION Topic: 20A001Radiation effects in microelectronics are a significant concern for DoD systems that operate at high altitudes or in outer space. Typical characterization efforts focus on macroscale degradation signatures from electrical measurements at device terminals. However, a comprehensive analysis of radiation-induced physical defects is not possible based solely on terminal measurements. CFD Research and ...
STTR Phase II 2022 Department of DefenseDefense Microelectronics Activity -
Develop and demonstrate a technology for isolation of bacteriophages with enhanced antibiofilm activity
SBC: CFD RESEARCH CORPORATION Topic: DHA20B003The twenty-first century has seen a global rise in bacterial infections exhibiting antimicrobial-resistance (AMR). More than ninety percent of chronic wounds contain microbial biofilms that exhibit AMR, and the bacteria responsible for several of these recalcitrant infections are called ESKAPEE pathogens. Eradicating ESKAPEE pathogenic infections is challenging, but bacteriophage (phage) therapy i ...
STTR Phase II 2022 Department of DefenseDefense Health Agency -
Flexible Microfluidic Process Technology for Biopharmaceutical Purification of Bacteriophages
SBC: CFD RESEARCH CORPORATION Topic: DHA21C002Multidrug resistant (MDR) bacterial wound infections remain a persistent challenge for front-line military medical providers in prolonged care treatment. Phage therapeutics have demonstrated preclinical and clinical efficacy against ESKAPEE infections. Phage production however remains a challenge to remove bacterial remnants including LPS endotoxins and other pyrogens. To meet regulatory requireme ...
STTR Phase I 2022 Department of DefenseDefense Health Agency